Torrent’s Entry Into Indian Trade Generics Signals Strategy Shift

US Launches Still Held Back

Faced with a slowdown in the US from a lack of regulatory approvals, Torrent Pharma is looking at alternate growth strategies. Its entry into the trade generics segment in India, joining other pharma majors, is one to be watched as it marks a strategic shift.

Generic Medicines
Trade Generics In India See An Increase In Interest • Source: Alamy

Torrent Pharmaceuticals Ltd. has joined the league of pharma majors with a trade generics portfolio in India, a move likely triggered by a slow down in the US, its largest overseas market, as well as a consumer segment’s preference for cheaper alternatives to branded generics. 

The current government’s focus on providing economical drugs through “Pradhan Mantri Bhartiya Janaushadhi Kendras”, or public medical retail outlets, has...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip